India’s Central Drugs Standard Control Organization (CDSCO) has proposed bringing the country’s Good Manufacturing Practice requirements for medical and in vitro diagnostic devices more in line with those of the ISO 13485 quality management system standard.

Manufacturers with ISO 13485-compliant quality systems already implemented should find the new CDSCO requirements familiar. If regulators ultimately adopt ISO 13485-based QMS requirements, such firms may find it advantageous and less complex to pursue registration of their devices in India.

CDSCO is accepting comments on its draft GMP changes through December 17, 2014. The regulator’s proposed amendments would affect quality system requirements under the country’s Drug and Cosmetic Act.